CLINICAL TRIALS PROFILE FOR IMIPRAMINE PAMOATE
✉ Email this page to a colleague
All Clinical Trials for IMIPRAMINE PAMOATE
Trial ID | Title | Status | Sponsor | Phase | Start Date | Summary |
---|---|---|---|---|---|---|
NCT01107353 ↗ | Bioequivalency Study of Imipramine Pamoate 75 mg Capsules Under Fasted Conditions | Completed | Roxane Laboratories | N/A | 2008-08-01 | The objective of this study was to prove the bioequivalence of Imipramine Pamoate 75 mg Capsules under fasting conditions |
NCT01389908 ↗ | A Follow up Study of Intramuscular Olanzapine Depot in Patients With Schizophrenia or Schizoaffective Disorder | Unknown status | Shalvata Mental Health Center | N/A | 2011-06-01 | The purpose of this study is to assess the long-term efficacy of Olanzapine Pamoate (OP) Depot in patients diagnosed with schizophrenia or schizoaffective disorder. |
>Trial ID | >Title | >Status | >Sponsor | >Phase | >Start Date | >Summary |
Clinical Trial Conditions for IMIPRAMINE PAMOATE
Condition Name
Clinical Trial Locations for IMIPRAMINE PAMOATE
Trials by Country
Clinical Trial Progress for IMIPRAMINE PAMOATE
Clinical Trial Phase
Clinical Trial Sponsors for IMIPRAMINE PAMOATE
Sponsor Name